SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-12-001607
Filing Date
2012-08-01
Accepted
2012-08-01 14:43:04
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 medizone10q063012.htm 10-Q 585678
2 ex31-1.htm EX-31.1 9963
3 ex31-2.htm EX-31.2 10444
4 ex32-1.htm EX-32.1 5198
5 ex32-2.htm EX-32.2 5078
  Complete submission text file 0001185185-12-001607.txt   2982884

Data Files

Seq Description Document Type Size
6 mzei-20120630.xml EX-101.INS 305347
7 mzei-20120630.xsd EX-101.SCH 34861
8 mzei-20120630_cal.xml EX-101.CAL 34565
9 mzei-20120630_def.xml EX-101.DEF 159626
10 mzei-20120630_lab.xml EX-101.LAB 234090
11 mzei-20120630_pre.xml EX-101.PRE 164711
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 12999630
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries